183 related articles for article (PubMed ID: 29744436)
1. Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system.
Dave V; Yadav RB; Kushwaha K; Yadav S; Sharma S; Agrawal U
Bioact Mater; 2017 Dec; 2(4):269-280. PubMed ID: 29744436
[TBL] [Abstract][Full Text] [Related]
2. Hybrid nanoparticles for the topical delivery of norfloxacin for the effective treatment of bacterial infection produced after burn.
Dave V; Kushwaha K; Yadav RB; Agrawal U
J Microencapsul; 2017 Jun; 34(4):351-365. PubMed ID: 28562141
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Design of Norfloxacin drug delivery system based on PLA/TiO
Salahuddin N; Abdelwahab M; Gaber M; Elneanaey S
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110337. PubMed ID: 31923987
[TBL] [Abstract][Full Text] [Related]
5. Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation.
Khan MA; Khan S; Kazi M; Alshehri SM; Shahid M; Khan SU; Hussain Z; Sohail M; Shafique M; Hamid HA; Kamran M; Elhissi A; Wasim M; Thu HE
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683925
[TBL] [Abstract][Full Text] [Related]
6. Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery.
Suares D; Prabhakar B
Drug Dev Ind Pharm; 2017 Feb; 43(2):213-224. PubMed ID: 27593545
[TBL] [Abstract][Full Text] [Related]
7. Novel Self-Assembled Polycaprolactone-Lipid Hybrid Nanoparticles Enhance the Antibacterial Activity of Ciprofloxacin.
Omer ME; Halwani M; Alenazi RM; Alharbi O; Aljihani S; Massadeh S; Al Ghoribi M; Al Aamery M; Yassin AE
SLAS Technol; 2020 Dec; 25(6):598-607. PubMed ID: 32734812
[TBL] [Abstract][Full Text] [Related]
8. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
Dhal C; Mishra R
Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
10. Hesperidin-Loaded Lipid Polymer Hybrid Nanoparticles for Topical Delivery of Bioactive Drugs.
Jangde R; Elhassan GO; Khute S; Singh D; Singh M; Sahu RK; Khan J
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215324
[TBL] [Abstract][Full Text] [Related]
11. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
13. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
14. Screening strategies for surface modification of lipid-polymer hybrid nanoparticles.
Rouco H; García-García P; Évora C; Díaz-Rodríguez P; Delgado A
Int J Pharm; 2022 Aug; 624():121973. PubMed ID: 35811041
[TBL] [Abstract][Full Text] [Related]
15. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design.
Gajra B; Dalwadi C; Patel R
Daru; 2015 Jan; 23(1):3. PubMed ID: 25604353
[TBL] [Abstract][Full Text] [Related]
17. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
18. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
19. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
20. Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation.
Pardeshi CV; Belgamwar VS; Tekade AR; Surana SJ
J Mater Sci Mater Med; 2013 Sep; 24(9):2101-15. PubMed ID: 23728521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
